Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators
Guardado en:
Autores principales: | Therese Hesketh, Jacqueline Spayne |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/822962fa7951465b9587dc59cfecbee2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Human papillomavirus vaccination: evidence base for efficacy and safety
por: Yuliya E. Dobrokhotova, et al.
Publicado: (2021) -
Human Papillomavirus Infection and Awareness of Human Pappillomavirus Vaccines among Various Ethnicities in Libya
por: Salma Korbag, et al.
Publicado: (2021) -
Efficacy and safety of human papillomavirus vaccination in HIV-infected patients: a systematic review and meta-analysis
por: Antonella Zizza, et al.
Publicado: (2021) -
Type-specific human papillomavirus biological features: validated model-based estimates.
por: Iacopo Baussano, et al.
Publicado: (2013) -
Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis.
por: Jane J Kim, et al.
Publicado: (2021)